ScholarIQanswers from OpenAlex

Transcription factor Nrf2 hyperactivation in early-phase renal ischemia-reperfusion injury prevents tubular damage progression

PaperCitations, authors & open-access status

Transcription factor Nrf2 hyperactivation in early-phase renal ischemia-reperfusion injury prevents tubular damage progression is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Transcription factor Nrf2 hyperactivation in early-phase renal ischemia-reperfusion injury prevents tubular damage progression have?

ScholarIQcitation count

Transcription factor Nrf2 hyperactivation in early-phase renal ischemia-reperfusion injury prevents tubular damage progression has 213 citations in the OpenAlex counts ScholarIQ stores.

When was Transcription factor Nrf2 hyperactivation in early-phase renal ischemia-reperfusion injury prevents tubular damage progression published?

ScholarIQyear

Transcription factor Nrf2 hyperactivation in early-phase renal ischemia-reperfusion injury prevents tubular damage progression has 2016 year in the ScholarIQ index.

What is the open-access status of Transcription factor Nrf2 hyperactivation in early-phase renal ischemia-reperfusion injury prevents tubular damage progression?

ScholarIQoa status

Transcription factor Nrf2 hyperactivation in early-phase renal ischemia-reperfusion injury prevents tubular damage progression has green oa status in the ScholarIQ index.

What is the DOI of Transcription factor Nrf2 hyperactivation in early-phase renal ischemia-reperfusion injury prevents tubular damage progression?

ScholarIQdoi

The DOI for Transcription factor Nrf2 hyperactivation in early-phase renal ischemia-reperfusion injury prevents tubular damage progression is on the source record.

What is the PMID of Transcription factor Nrf2 hyperactivation in early-phase renal ischemia-reperfusion injury prevents tubular damage progression?

ScholarIQpmid

The PMID for Transcription factor Nrf2 hyperactivation in early-phase renal ischemia-reperfusion injury prevents tubular damage progression is on the source record.

What is the OpenAlex record for Transcription factor Nrf2 hyperactivation in early-phase renal ischemia-reperfusion injury prevents tubular damage progression?

ScholarIQopenalex

The OpenAlex for Transcription factor Nrf2 hyperactivation in early-phase renal ischemia-reperfusion injury prevents tubular damage progression is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial